ReviewFrontiers in pharmacology2021

Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases.

Yiming Leng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.